We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.61B
1-Year Est. Return
28.28%
This Fund
S&P 500
This Quarter
Est. Return
+14.21%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$987M
AUM Growth
+$120M
(+14%)
Cap. Flow
+$63.5M
Cap. Flow
% of AUM
6.44%
Top 10 Holdings %
Top 10 Hldgs %
5.22%
Holding
1,870
New
579
Increased
363
Reduced
419
Closed
480
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$6.71M |
| 2 |
DexCom
DXCM
|
+$6.59M |
| 3 |
X
US Steel
X
|
+$6.1M |
| 4 |
CMBT
CMB.TECH NV
CMBT
|
+$5.09M |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$4.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GOOS
Canada Goose Holdings
GOOS
|
+$21.9M |
| 2 |
Constellation Brands
STZ
|
+$9.52M |
| 3 |
Lumen
LUMN
|
+$7.13M |
| 4 |
Weyerhaeuser
WY
|
+$6.3M |
| 5 |
FedEx
FDX
|
+$6.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.75% |
| 2 | Technology | 15.19% |
| 3 | Consumer Discretionary | 13.45% |
| 4 | Industrials | 12.06% |
| 5 | Financials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Check Point Software Technologies
CHKP
$12.8B
| $1.16M | 0.12% |
9,200
| – | – |
|
|
EGRX
227
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.16M | 0.12% |
23,052
-9,348
| -29% | -$416K |
|
|
VRS
228
DELISTED
Verso Corporation
VRS
| $1.16M | 0.12% |
54,289
+4,703
| +9% | +$109K |
|
|
IDTI
229
DELISTED
Integrated Device Technology I
IDTI
| $1.16M | 0.12% |
23,731
-2,375
| -9% | -$115K |
|
230
PTC Therapeutics
PTCT
$5.78B
| $1.16M | 0.12% |
30,832
+7,632
| +33% | +$256K |
|
231
Gran Tierra Energy
GTE
$334M
| $1.16M | 0.12% |
51,017
+32,202
| +171% | +$755K |
|
232
Paylocity
PCTY
$8.18B
| $1.15M | 0.12% |
+12,926
| New | +$1M |
|
233
Tactile Systems Technology
TCMD
$676M
| $1.15M | 0.12% |
21,852
+2,485
| +13% | +$161K |
|
234
Teck Resources
TECK
$32.4B
| $1.15M | 0.12% |
49,576
-66,966
| -57% | -$1.51M |
|
235
Oceaneering
OII
$4.78B
| $1.15M | 0.12% |
+72,825
| New | +$1.13M |
|
236
Eli Lilly
LLY
$1.04T
| $1.14M | 0.12% |
8,809
-532
| -6% | -$64.7K |
|
237
TripAdvisor
TRIP
$1.63B
| $1.14M | 0.12% |
+22,135
| New | +$1.21M |
|
238
Welltower
WELL
$171B
| $1.13M | 0.11% |
14,568
+11,504
| +375% | +$863K |
|
239
Live Nation Entertainment
LYV
$42.8B
| $1.13M | 0.11% |
+17,774
| New | +$1.01M |
|
240
Unum
UNM
$14.1B
| $1.12M | 0.11% |
+33,217
| New | +$1.16M |
|
|
HOME
241
DELISTED
At Home Group Inc.
HOME
| $1.12M | 0.11% |
62,953
+42,208
| +203% | +$935K |
|
|
HIBB
242
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $1.12M | 0.11% |
49,260
-27,840
| -36% | -$490K |
|
|
ARCH
243
DELISTED
Arch Resources, Inc.
ARCH
| $1.12M | 0.11% |
12,300
| – | – |
|
244
AMC Entertainment Holdings
AMC
$2.38B
| $1.12M | 0.11% |
7,543
+103
| +1% | +$14.7K |
|
245
TJX Companies
TJX
$177B
| $1.12M | 0.11% |
21,046
+13,886
| +194% | +$692K |
|
246
Axalta
AXTA
$8.15B
| $1.12M | 0.11% |
+44,326
| New | +$1.14M |
|
247
Commault Systems
CVLT
$5.52B
| $1.12M | 0.11% |
+17,241
| New | +$1.11M |
|
248
Enovis
ENOV
$1.74B
| $1.12M | 0.11% |
+21,837
| New | +$957K |
|
249
Host Hotels & Resorts
HST
$17.2B
| $1.11M | 0.11% |
58,955
+30,059
| +104% | +$555K |
|
250
Emerson Electric
EMR
$90.6B
| $1.11M | 0.11% |
+16,182
| New | +$1.06M |
|
Similar funds
ACB
SCI
SCM
BW
HH
KCM
PRA
CC
GSA Capital Partners's Q1 2019 Portfolio in Review
As of Q1 2019, GSA Capital Partners held 1,870 positions worth $987M, up 14% from $867M the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.
GSA Capital Partners deployed $63.5M of net new capital in Q1 2019, opening 579 new positions and adding to 363 existing holdings. Its largest new stake was DexCom: 187,420 shares worth $5.58M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Lumen, an estimated $7.13M trimmed.
- GSA Capital Partners's largest Q1 2019 buy was DexCom: 187,420 shares worth $5.58M.
- GSA Capital Partners added most to Biogen in Q1 2019, an estimated $6.71M increase.
- GSA Capital Partners's biggest Q1 2019 reduction was Lumen, cutting an estimated $7.13M.
- GSA Capital Partners fully exited Canada Goose Holdings in Q1 2019, selling an estimated $21.9M.
- GSA Capital Partners's ten largest holdings make up 5.2% of its $987M portfolio in Q1 2019.
- GSA Capital Partners opened 579 new positions and closed 480 in Q1 2019.
- GSA Capital Partners's portfolio value rose 14% quarter-over-quarter to $987M.
Based on GSA Capital Partners's 13F filing for Q1 2019, filed 15 May 2019.